ATTENUATION OF 5-HT1A AND 5-HT2 BUT NOT 5-HT1C RECEPTOR MEDIATED BEHAVIOR IN RATS FOLLOWING CHRONIC TREATMENT WITH 5-HT RECEPTOR AGONISTS, ANTAGONISTS OR ANTI-DEPRESSANTS

被引:46
|
作者
BERENDSEN, HHG
BROEKKAMP, CLE
机构
[1] Department of CNS Pharmacology, Organon International B.V., Oss, NL-5340 BH
关键词
CHRONIC TREATMENT; 5-HT RECEPTOR SUBTYPES; LOWER LIP RETRACTION; PENILE ERECTIONS; HEAD SHAKES; ANTIDEPRESSANTS; RAT;
D O I
10.1007/BF02244313
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of chronic (10 days) treatment with serotonin (5-HT) receptor agonists on 5-HT1A receptor mediated lower lip retraction (LLR), 5-HT1C receptor mediated penile erections (PE) or 5-HT2 receptor mediated head shakes (HS) were studied in rats. It was found that the 5-HT1A and 5-HT2 receptor mediated behaviour could be attenuated after chronic treatment, whereas 5-HT1C receptor mediated behaviour remained unchanged. The ED50 for the 5-HT1A receptor mediated, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)-induced LLR showed an increase from 0.07 mg/kg in placebo pretreated rats to 0.13 in 8-OH-DPAT (1 mg/kg/day) pretreated rats. The number of 5-HT2 receptor mediated (+/-)-1-2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) (0.46 and 1 mg/kg)-induced HS was significantly reduced (67% and 50%, respectively) after 10 days' pretreatment with DOI (1 mg/kg/day). In the same animals the number of 5-HT1C receptor mediated PE was increased. Ten days' pretreatment with MK 212 (0.46 mg/kg/day) failed to affect MK 212 (0.22 and 0.46 mg/kg/)-induced PE. In addition, the effects of chronic treatment with some antidepressants were studied. The monoamine oxidase (MAO) inhibitor tranylcypromine (4 mg/kg/day) given for 10 days caused an increase in the ED50 for 8-OH-DPAT induced LLR (ED50 values were 0.06 and 0.14 mg/kg, respectively, in placebo - and tranylcypromine - pretreated rats) and attenuated MK 212 (0.22 and 0.46 mg/kg)-induced PE. Chronic treatment with mianserin (10 mg/kg/day), a tetracyclic antidepressant with 5-HT1C and 5-HT2 receptor antagonistic properties, did not change PE induced by MK 212, but caused an increase of PE induced by DOI and a decrease of DOI-induced HS. Ten days' pretreatment with the 5-HT re-uptake inhibitor Org 6997 (5 mg/kg/day) had no effect on MK 212-induced PE. The results demonstrate that 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour can be attenuated by chronic treatment with agonists for these receptors. The 5-HT1C receptor mediated behaviour remains unchanged in response to chronic agonist treatment. Chronic treatment with anti-depressants have differential effect on these behaviours. The possible implication for the mechanism of action of antidepressants is discussed.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 50 条
  • [1] EFFECTS OF COLD STRESS ON SOME 5-HT1A, 5-HT1C AND 5-HT2 RECEPTOR-MEDIATED RESPONSES
    ZAMFIR, O
    BROQUA, P
    BAUDRIE, V
    CHAOULOFF, F
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (02) : 261 - 269
  • [2] CENTRAL ADMINISTRATION OF 5-HT ACTIVATES 5-HT1A RECEPTORS TO CAUSE SYMPATHOEXCITATION AND 5-HT2/5-HT1C RECEPTORS TO RELEASE VASOPRESSIN IN ANESTHETIZED RATS
    ANDERSON, IK
    MARTIN, GR
    RAMAGE, AG
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) : 1020 - 1028
  • [3] BEHAVIORAL PHARMACOLOGY OF ANTAGONISTS AT 5-HT2/5-HT1C RECEPTORS
    KOEK, W
    JACKSON, A
    COLPAERT, FC
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01): : 95 - 105
  • [4] CLONING OF THE HUMAN SEROTONIN 5-HT2 AND 5-HT1C RECEPTOR SUBTYPES
    SALTZMAN, AG
    MORSE, B
    WHITMAN, MM
    IVANSHCHENKO, Y
    JAYE, M
    FELDER, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (03) : 1469 - 1478
  • [5] Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior
    Uphouse, L
    White, S
    Harrison, L
    Hiegel, C
    Majumdar, D
    Guptarak, J
    Truitt, WA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 76 (01) : 63 - 73
  • [6] EFFECT OF SELECTIVE 5-HT1A AGONISTS AND 5-HT2 ANTAGONISTS ON INHERITED CATALEPSY IN RATS
    KULIKOV, AV
    KOLPAKOV, VG
    MASLOVA, GB
    KOZINTSEV, I
    POPOVA, NK
    PSYCHOPHARMACOLOGY, 1994, 114 (01) : 172 - 174
  • [7] EFFECT OF CHRONIC INTRACEREBROVENTRICULAR 5-HT1C RECEPTOR ANTISERUM INFUSION ON THE 5-HT BEHAVIORAL SYNDROME AND 5-HT TURNOVER
    FONE, KCF
    SHARMA, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 : P97 - P97
  • [8] REGULATION OF 5-HT2 AND 5-HT1C SEROTONIN RECEPTOR LEVELS - METHODOLOGY AND MECHANISMS
    ROTH, BL
    HAMBLIN, M
    CIARANELLO, RD
    NEUROPSYCHOPHARMACOLOGY, 1990, 3 (5-6) : 427 - 433
  • [9] CHRONIC 5-HT2 RECEPTOR ANTAGONIST TREATMENT ALTERS 5-HT1A AUTOREGULATORY CONTROL OF 5-HT RELEASE IN RAT-BRAIN INVIVO
    KIDD, EJ
    LEYSEN, JE
    MARSDEN, CA
    JOURNAL OF NEUROSCIENCE METHODS, 1990, 34 (1-3) : 91 - 98
  • [10] 5-HT1C receptor
    Hartig, Paul R.
    Hoffman, Beth J.
    Kaufman, Marc J.
    Hirata, Fusao
    Annals of the New York Academy of Sciences, 1990, 600